vs

Side-by-side financial comparison of BayCom Corp (BCML) and CVRx, Inc. (CVRX). Click either name above to swap in a different company.

BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $16.0M, roughly 1.6× CVRx, Inc.). BayCom Corp runs the higher net margin — 26.5% vs -74.5%, a 101.0% gap on every dollar of revenue. On growth, BayCom Corp posted the faster year-over-year revenue change (9.4% vs 4.4%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $-9.8M). Over the past eight quarters, CVRx, Inc.'s revenue compounded faster (22.0% CAGR vs 2.9%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

BCML vs CVRX — Head-to-Head

Bigger by revenue
BCML
BCML
1.6× larger
BCML
$25.9M
$16.0M
CVRX
Growing faster (revenue YoY)
BCML
BCML
+5.0% gap
BCML
9.4%
4.4%
CVRX
Higher net margin
BCML
BCML
101.0% more per $
BCML
26.5%
-74.5%
CVRX
More free cash flow
BCML
BCML
$39.9M more FCF
BCML
$30.1M
$-9.8M
CVRX
Faster 2-yr revenue CAGR
CVRX
CVRX
Annualised
CVRX
22.0%
2.9%
BCML

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCML
BCML
CVRX
CVRX
Revenue
$25.9M
$16.0M
Net Profit
$6.9M
$-11.9M
Gross Margin
86.3%
Operating Margin
36.6%
-69.8%
Net Margin
26.5%
-74.5%
Revenue YoY
9.4%
4.4%
Net Profit YoY
12.1%
-12.0%
EPS (diluted)
$0.63
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
CVRX
CVRX
Q4 25
$25.9M
$16.0M
Q3 25
$25.7M
$14.7M
Q2 25
$24.7M
$13.6M
Q1 25
$24.3M
$12.3M
Q4 24
$23.7M
$15.3M
Q3 24
$25.6M
$13.4M
Q2 24
$23.8M
$11.8M
Q1 24
$24.5M
$10.8M
Net Profit
BCML
BCML
CVRX
CVRX
Q4 25
$6.9M
$-11.9M
Q3 25
$5.0M
$-12.9M
Q2 25
$6.4M
$-14.7M
Q1 25
$5.7M
$-13.8M
Q4 24
$6.1M
$-10.7M
Q3 24
$6.0M
$-13.1M
Q2 24
$5.6M
$-14.0M
Q1 24
$5.9M
$-22.2M
Gross Margin
BCML
BCML
CVRX
CVRX
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
Q1 24
85.0%
Operating Margin
BCML
BCML
CVRX
CVRX
Q4 25
36.6%
-69.8%
Q3 25
26.3%
-83.5%
Q2 25
35.3%
-105.8%
Q1 25
31.6%
-108.8%
Q4 24
34.2%
-67.0%
Q3 24
32.4%
-97.3%
Q2 24
31.9%
-118.3%
Q1 24
33.3%
-206.4%
Net Margin
BCML
BCML
CVRX
CVRX
Q4 25
26.5%
-74.5%
Q3 25
19.5%
-87.6%
Q2 25
25.8%
-108.4%
Q1 25
23.4%
-111.5%
Q4 24
25.9%
-69.4%
Q3 24
23.5%
-98.0%
Q2 24
23.6%
-118.8%
Q1 24
24.0%
-206.0%
EPS (diluted)
BCML
BCML
CVRX
CVRX
Q4 25
$0.63
$-0.45
Q3 25
$0.46
$-0.49
Q2 25
$0.58
$-0.57
Q1 25
$0.51
$-0.53
Q4 24
$0.55
$-0.39
Q3 24
$0.54
$-0.57
Q2 24
$0.50
$-0.65
Q1 24
$0.51
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
CVRX
CVRX
Cash + ST InvestmentsLiquidity on hand
$75.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.6M
$39.3M
Total Assets
$2.6B
$104.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
CVRX
CVRX
Q4 25
$75.7M
Q3 25
$85.1M
Q2 25
$95.0M
Q1 25
$102.7M
Q4 24
$105.9M
Q3 24
$100.2M
Q2 24
$70.4M
Q1 24
$80.1M
Stockholders' Equity
BCML
BCML
CVRX
CVRX
Q4 25
$338.6M
$39.3M
Q3 25
$334.3M
$48.1M
Q2 25
$330.6M
$57.9M
Q1 25
$329.3M
$71.1M
Q4 24
$324.4M
$71.1M
Q3 24
$321.7M
$65.2M
Q2 24
$315.3M
$55.2M
Q1 24
$314.2M
$66.3M
Total Assets
BCML
BCML
CVRX
CVRX
Q4 25
$2.6B
$104.8M
Q3 25
$2.6B
$111.3M
Q2 25
$2.6B
$119.6M
Q1 25
$2.6B
$129.6M
Q4 24
$2.7B
$133.4M
Q3 24
$2.6B
$127.7M
Q2 24
$2.6B
$96.0M
Q1 24
$2.6B
$106.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
CVRX
CVRX
Operating Cash FlowLast quarter
$31.8M
$-9.8M
Free Cash FlowOCF − Capex
$30.1M
$-9.8M
FCF MarginFCF / Revenue
116.2%
-61.3%
Capex IntensityCapex / Revenue
6.7%
0.4%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$51.1M
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
CVRX
CVRX
Q4 25
$31.8M
$-9.8M
Q3 25
$7.3M
$-9.7M
Q2 25
$6.4M
$-7.9M
Q1 25
$9.3M
$-12.8M
Q4 24
$30.4M
$-8.0M
Q3 24
$9.6M
$-10.4M
Q2 24
$7.7M
$-9.8M
Q1 24
$5.1M
$-10.9M
Free Cash Flow
BCML
BCML
CVRX
CVRX
Q4 25
$30.1M
$-9.8M
Q3 25
$6.2M
$-10.0M
Q2 25
$5.6M
$-8.0M
Q1 25
$9.1M
$-12.9M
Q4 24
$28.7M
$-8.1M
Q3 24
$9.4M
$-10.4M
Q2 24
$7.4M
$-10.2M
Q1 24
$3.9M
$-11.8M
FCF Margin
BCML
BCML
CVRX
CVRX
Q4 25
116.2%
-61.3%
Q3 25
24.3%
-68.1%
Q2 25
22.8%
-59.2%
Q1 25
37.6%
-104.3%
Q4 24
121.1%
-52.5%
Q3 24
36.6%
-78.1%
Q2 24
31.2%
-86.3%
Q1 24
16.1%
-109.7%
Capex Intensity
BCML
BCML
CVRX
CVRX
Q4 25
6.7%
0.4%
Q3 25
4.3%
2.0%
Q2 25
3.0%
0.8%
Q1 25
0.6%
0.9%
Q4 24
7.2%
0.3%
Q3 24
1.0%
0.3%
Q2 24
1.0%
3.0%
Q1 24
4.7%
8.5%
Cash Conversion
BCML
BCML
CVRX
CVRX
Q4 25
4.64×
Q3 25
1.47×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BCML
BCML

Segment breakdown not available.

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

Related Comparisons